The mean costs of 2-year post-transplant care for each regimen were only displayed in a diagram and were not reported in the main text of the paper. As such, the results reported here have been estimated from the graph.
For group 1:
the total cost was EUR 15,759;
the cost of SRL was EUR 6,754;
the cost of other immunosuppressive agents was EUR 3,377;
the cost of days in hospital was EUR 3,752; and
other costs were EUR 1,876.
For group 2:
the total cost was EUR 25,593 (note, when the total cost was estimated from the graph it was 25,515);
the cost of SRL was EUR 12,382;
the cost of other immunosuppressive agents was EUR 7,880;
the cost of days in hospital was EUR 3,002; and
other costs were EUR 2,251.
For group 3:
the total cost was EUR 21,197 (note, when the total cost was estimated from the graph it was 21,013);
the cost of SRL was EUR 13,133;
the cost of other immunosuppressive agents was EUR 1,501;
the cost of days in hospital was EUR 3,377; and
other costs were EUR 3,002.
For the sensitivity analysis a realistic assumption of +/- 20% fluctuations in the costs confirmed that the results were not dependent on changes in costs connected with them.